Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.251 USD | +1.20% | -0.92% | -22.72% |
Apr. 30 | Ladenburg Thalmann Starts Marker Therapeutics With Buy Rating, $11 Price Target | MT |
Mar. 27 | North American Morning Briefing : Stocks Edge -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.72% | 37.44M | |
+25.64% | 48.09B | |
+47.53% | 40.62B | |
-2.48% | 40.43B | |
-6.95% | 28.36B | |
+7.63% | 24.89B | |
-19.94% | 19.01B | |
+29.10% | 12.09B | |
-1.04% | 11.88B | |
-0.80% | 11.8B |
- Stock Market
- Equities
- MRKR Stock
- News Marker Therapeutics, Inc.
- Marker Therapeutics : Cantor Fitzgerald Initiates Marker Therapeutics at Overweight Rating With $6 Price Target